Reach Us +1-218-451-2974


Editor - Hema Krishnan | Massachusetts General Hospital | 26901
ISSN: 2161-0460

Journal of Alzheimers Disease & Parkinsonism
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences
Google scholar citation report
Citations : 2275

Journal of Alzheimers Disease & Parkinsonism received 2275 citations as per google scholar report

Journal of Alzheimers Disease & Parkinsonism peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • China National Knowledge Infrastructure (CNKI)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

Hema Krishnan

Hema Krishnan
Hema Krishnan
Research Scientist
Martinos Center for Biomedical Imaging (Hooker Lab) 
Massachusetts General Hospital
Massachusetts General Hospital


I received my PhD from the University of Southern California in Los Angeles studying fluoroalkylation reactions under the guidance of Dr. G. K. Surya Prakash and 1994 Chemistry Nobel Laureate, late Prof. George A. Olah. Following my graduation, I moved across the United States to start a postdoctoral fellowship at the Massachusetts General Hospital/ Harvard Medical School (MGH/HMS). In my five years here, I have worked on several projects involving the synthesis and design of radiotracers to probe various facets of neuroinflammation and neurodegenerative diseases, specifically Alzheimer's disease. I have also participated in several imaging studies in rodents and non-human primates and worked on image and radiometabolite analysis. In my current position, I am working on translating a dopamine agonist radiotracer for human imaging and developing novel brain penetrant radiotracers to study neuroinflammation.

Research Interest

Development of PET radiotracers to study neuroinflammation and neurodegenerative diseases